What This Report Will Provide?
This study involved four major activities in estimating the current size of the oligonucleotide synthesis market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.
Expected Revenue Growth:
[246 Pages Report] The global oligonucleotide synthesis market is projected to reach USD 14.1 billion by 2026 from USD 6.3 billion in 2021, at a CAGR of 17.6%
Major Growth Boosters:
This market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques, increasing government funding, and the growing focus on personalized medicine.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350
Recent Developments:
In 2020, Danaher Corporation (US) opened IDT China, an official business entity, to better serve its customer base in the region, reach out to new customers, and provide easier access to its complete portfolio of industry-leading products.
In 2020, Danaher (US) acquired the Biopharma business from General Electric Company's (US) Life Sciences division. This subsidiary is called ‘Cytiva’ and will act as a standalone operating company within Danaher's Life Sciences segment. This acquisition strengthened Danaher’s position in the oligo synthesizer and reagents market.
In 2020, Microsynth AG (Switzerland) launched Primer-Probe Sets for SARS-CoV-2.
In 2020, LGC Limited (UK) partnered with the Paraná Institute of Molecular Biology (IBMP) (Brazil) to supply reliable, high-quality custom GMP oligonucleotides and molecular products to develop a new molecular test for ZDC (zika, dengue, and chikungunya).
Key Questions Addressed in The Report:
1. Who are the top 10 players operating in the global oligonucleotide synthesis market?
2. What are the drivers, restraints, opportunities, and challenges in the oligonucleotide synthesis Industry?
3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of oligonucleotide synthesis in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?
Regional Growth Analysis:
In 2020, North America accounted for the largest market share. The large share of this region can be attributed to the increasing R&D in life sciences, rising focus on improving the safety & quality of healthcare, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics. The presence of many global players in this region is another key factor contributing to the large share of this market segment
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=200829350
Key Players in Oligonucleotide Synthesis Market:
The oligonucleotide synthesis market is dominated by a few globally established players such as Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), LGC Limited (UK), Maravai Life Sciences (US). The prominent players in the oligonucleotide therapeutics market are Biogen Inc. (US) and Sarepta Therapeutics, Inc. (US).
Oligonucleotide Synthesis Market in Therapeutic Application is Growing at 17.6%
Oligonucleotide Synthesis Market’s ProspectThe global oligonucleotide synthesis market is expecting an astonishing 10.3% CAGR during the forecast period (2014-2022), reveals Market Research Future (MRFR) in a broadly demonstrated report.The report further incorporates factors that are contributing much for the market growth which includes ventures and investments made by big pharmaceutical companies, contract manufacturing organization’s involvement in the market and global prevalence of chronic diseases spurring the demand for better medicines.Get Free sample Research Copy@ https://www.marketresearchfuture.com/sample_request/2337However, the cost can prove to be a great market deterrent.
But it has the potential to counter chronic diseases by developing suitable drugs which can create a favorable ambiance for the market.Segmentation:The global oligonucleotide synthesis market can be segmented by product type, application, and end-users.Based on product type, the market can be segmented into synthesized oligonucleotides, reagents and equipment.Application-wise segmentation of the market includes diagnostic, genetic testing, research, therapeutics, gene synthesis, library preparation, drug target screening, and others.
The region invests in research and development substantially, and it has a superlative infrastructure in biotechnology sector which is triggering further market growth.
Governments and private investors are also funding researches as they are equally eager to get positive results.Europe is also fetching in substantial revenue as the region has almost similar kind of ambiance like North America for advanced researches.
And its position has further been solidified by the presence of big league market players.
The APAC region is showing lots of promises as emerging economies such as India and China are investing heavily in biotechnological researches and developments which is directly expanding the scope for oligonucleotide synthesis market growth.
This report focuses on top manufacturers in global market, with Sales, price, revenue and market share for each manufacturer, coveringGenescriptGeneArt (Thermofischer)IDTDNA 2.0 (ATUM)OriGeneBBIGenewizEurofins GenomicsGene OracleSBS GenetechBio BasicDownload FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-oligonucleotide-synthesis-2018-994On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split intoPrimersProbesIntermediate-scale Synthesis OligosLarge-scale Synthesis OligosLinkers and AdaptorsBy Application, the market can be split intoChinaUSAEuropeJapanKoreaIndiaSoutheast AsiaSouth AmericaBy Regions, this report covers (we can add the regions/countries as you want)If you have any special requirements, please let us know and we will offer you the report as you want.Get the Complete Report & TOC @ https://www.grandresearchstore.com/energy-and-natural-resources/global-oligonucleotide-synthesis-2018-994Table of content1 Report Overview1.1 Definition and Specification1.2 Report Overview1.2.1 Manufacturers Overview1.2.2 Regions Overview1.2.3 Type Overview1.2.4 Application Overview1.3 Industrial Chain1.3.1 Oligonucleotide Synthesis Overall Industrial Chain1.3.2 Upstream1.3.3 Downstream1.4 Industry Situation1.4.1 Industrial Policy1.4.2 Product Preference1.4.3 Economic/Political Environment1.5 SWOT Analysis2 Market Analysis by Types2.1 Overall Market Performance(Volume)2.1.1 Primers Market Performance (Volume)2.1.2 Probes Market Performance (Volume)2.1.3 Intermediate-scale Synthesis Oligos Market Performance (Volume)2.1.4 Large-scale Synthesis Oligos Market Performance (Volume)2.1.5 Linkers and Adaptors Market Performance (Volume)2.2 Overall Market Performance(Value)2.1.1 Primers Market Performance (Value)2.1.2 Probes Market Performance (Value)2.1.3 Intermediate-scale Synthesis Oligos Market Performance (Value)2.1.4 Large-scale Synthesis Oligos Market Performance (Value)2.1.5 Linkers and Adaptors Market Performance (Value)3 Product Application Market3.1 Overall Market Performance (Volume)CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170 / +91 8087042414Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
Oligonucleotide Synthesis market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.
Oligonucleotide Synthesis Market Dynamics: Impact Analysis 1.
R Expenditure in Pharmaceutical and Biotechnology Companies The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7% Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global Oligonucleotide Synthesis market?
What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
Therapeutic applications: The therapeutic applications segment, which is further segmented into RNAi oligonucleotide-based therapies, DNA & antisense oligonucleotide-based therapies, and CpG oligonucleotide-based therapies, is estimated to witness the highest growth during the forecast period.
Also, from 2016 to 2018, more than five oligonucleotide-based therapies were approved by the FDA.
Oligonucleotide Synthesis Market’s ProspectThe global oligonucleotide synthesis market is expecting an astonishing 10.3% CAGR during the forecast period (2014-2022), reveals Market Research Future (MRFR) in a broadly demonstrated report.The report further incorporates factors that are contributing much for the market growth which includes ventures and investments made by big pharmaceutical companies, contract manufacturing organization’s involvement in the market and global prevalence of chronic diseases spurring the demand for better medicines.Get Free sample Research Copy@ https://www.marketresearchfuture.com/sample_request/2337However, the cost can prove to be a great market deterrent.
But it has the potential to counter chronic diseases by developing suitable drugs which can create a favorable ambiance for the market.Segmentation:The global oligonucleotide synthesis market can be segmented by product type, application, and end-users.Based on product type, the market can be segmented into synthesized oligonucleotides, reagents and equipment.Application-wise segmentation of the market includes diagnostic, genetic testing, research, therapeutics, gene synthesis, library preparation, drug target screening, and others.
The region invests in research and development substantially, and it has a superlative infrastructure in biotechnology sector which is triggering further market growth.
Governments and private investors are also funding researches as they are equally eager to get positive results.Europe is also fetching in substantial revenue as the region has almost similar kind of ambiance like North America for advanced researches.
And its position has further been solidified by the presence of big league market players.
The APAC region is showing lots of promises as emerging economies such as India and China are investing heavily in biotechnological researches and developments which is directly expanding the scope for oligonucleotide synthesis market growth.
This report focuses on top manufacturers in global market, with Sales, price, revenue and market share for each manufacturer, coveringGenescriptGeneArt (Thermofischer)IDTDNA 2.0 (ATUM)OriGeneBBIGenewizEurofins GenomicsGene OracleSBS GenetechBio BasicDownload FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-oligonucleotide-synthesis-2018-994On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split intoPrimersProbesIntermediate-scale Synthesis OligosLarge-scale Synthesis OligosLinkers and AdaptorsBy Application, the market can be split intoChinaUSAEuropeJapanKoreaIndiaSoutheast AsiaSouth AmericaBy Regions, this report covers (we can add the regions/countries as you want)If you have any special requirements, please let us know and we will offer you the report as you want.Get the Complete Report & TOC @ https://www.grandresearchstore.com/energy-and-natural-resources/global-oligonucleotide-synthesis-2018-994Table of content1 Report Overview1.1 Definition and Specification1.2 Report Overview1.2.1 Manufacturers Overview1.2.2 Regions Overview1.2.3 Type Overview1.2.4 Application Overview1.3 Industrial Chain1.3.1 Oligonucleotide Synthesis Overall Industrial Chain1.3.2 Upstream1.3.3 Downstream1.4 Industry Situation1.4.1 Industrial Policy1.4.2 Product Preference1.4.3 Economic/Political Environment1.5 SWOT Analysis2 Market Analysis by Types2.1 Overall Market Performance(Volume)2.1.1 Primers Market Performance (Volume)2.1.2 Probes Market Performance (Volume)2.1.3 Intermediate-scale Synthesis Oligos Market Performance (Volume)2.1.4 Large-scale Synthesis Oligos Market Performance (Volume)2.1.5 Linkers and Adaptors Market Performance (Volume)2.2 Overall Market Performance(Value)2.1.1 Primers Market Performance (Value)2.1.2 Probes Market Performance (Value)2.1.3 Intermediate-scale Synthesis Oligos Market Performance (Value)2.1.4 Large-scale Synthesis Oligos Market Performance (Value)2.1.5 Linkers and Adaptors Market Performance (Value)3 Product Application Market3.1 Overall Market Performance (Volume)CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170 / +91 8087042414Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
Oligonucleotide Synthesis market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.
Oligonucleotide Synthesis Market Dynamics: Impact Analysis 1.
R Expenditure in Pharmaceutical and Biotechnology Companies The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7% Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global Oligonucleotide Synthesis market?
What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
Therapeutic applications: The therapeutic applications segment, which is further segmented into RNAi oligonucleotide-based therapies, DNA & antisense oligonucleotide-based therapies, and CpG oligonucleotide-based therapies, is estimated to witness the highest growth during the forecast period.
Also, from 2016 to 2018, more than five oligonucleotide-based therapies were approved by the FDA.